Soluble PD-1 (sPD-1) can inhibit the function of the PD-L1/PD-1 signalling axis in RA patients to induce immune tolerance, leading to excessive activation of the T cell immune response and driving the occurrence and development of RA [44]. Here, PDCD1 is linked to rheumatoid arthritis.